Scandion Oncology A/S Logo

Scandion Oncology A/S

Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.

SCOL | ST

Overview

Corporate Details

ISIN(s):
DK0061031895 (+3 more)
LEI:
549300MPWDMQ5LZEGD09
Country:
Denmark
Address:
Fruebjergvej 3, 2100 København Ø
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Scandion Oncology A/S is a biotechnology company currently under liquidation. Previously, it operated as a clinical-stage company focused on developing first-in-class medicines to overcome cancer drug resistance. The company's primary mission was to revert resistance to existing anti-cancer therapies. Its lead compound, SCO-101, was being developed as an oral, add-on drug for use in combination with standard chemotherapy to improve treatment efficacy for cancer patients.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Scandion Oncology A/S filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Scandion Oncology A/S

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Scandion Oncology A/S via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Israel KVSR
Almirall S.A. Logo
A global biopharmaceutical company developing innovative medical solutions for skin health.
Spain ALM
Alteogen Inc. Logo
Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.
South Korea 196170
Alvotech Holdings S.A Logo
Develops and manufactures affordable biosimilar medicines for global patient access.
Luxembourg ALVO
Alzinova AB Logo
Developing targeted immunotherapies, including a vaccine, for Alzheimer's disease.
Sweden ALZ
Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea 092040
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea 074430
Amphastar Pharmaceuticals Inc. Logo United States of America AMPH
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom N/A
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.